Oxnard, CA’s FOMAT Medical Research Secures Two Big Clinical Trials with Regeneron Investigating REGN-COV2

Oxnard, CA’s FORMAT Medical Research Secures Two Big Clinical Trials with Regeneron Investigating REGN-COV2

Although perhaps not a household name among big pharmaceutical sponsors perhaps that may change as FOMAT Medical Research in Oxnard, California, recently secured a major contract with Regeneron to participate in their highly watched, Operation Warp Speed-funded REGN-COV2 double antibody COVID-19 clinical trial. The Southern California-based research organization starts two trials with the New York State-based sponsor chief, Nicholas Focil, who now faces “the most important study of my career.”

The SMO

The Oxnard-based research company “facilities clinical trials.” The “Integrated Research Organization” also known as a “Site Management Organization” (SMO) was profiled as part of the TrialSite’s global SMO survey back in early December, 2019. An independent operation, Fomat Medical Research has aligned with the hyperCORE International, a “Super Site Network” that purports to standardize systems and processes including business development. With over a decade of experience conducting Phase 1 to 4 clinical trials across a variety of therapeutic areas, they offer SMO and site services for up to 50 sites, SMO employs between 25 and 50 employees. Fomat claims to...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee